<DOC>
	<DOCNO>NCT00938496</DOCNO>
	<brief_summary>This prospective , open label NIS , assess efficacy Zoladex adjuvant setting operation moderate severe endometriosis patient .</brief_summary>
	<brief_title>Non-Interventional Study Zoladex Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Advanced endometriosis confirm histologically ( rAFS score IIIIV ) conservative laparoscopy laparotomy . Patient indication Zoladex prescribe Zoladex accord physician 's judgement , irrespective inclusion study . Patient already prescribe Zoladex within 1 month operation . Have use hormone treatment prior 3 month recruitment . Involvement plan conduct study ( applies AstraZeneca staff staff study site ) . Previous enrolment present study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>